Olfactory Bulb Shrinkage May Signal Early Cognitive Decline, With Aging Accounting for 40% of Parkinson's-Related Loss: Suggests Review
A recent systematic review published in the Indian Journal of Radiology and Imaging reveals that tracking olfactory bulb shrinkage offers a powerful, non-invasive early warning sign for cognitive decline. While neurodegenerative conditions severely accelerate this natural volume loss, researchers remarkably found that at least 40% of the profound shrinkage seen in Parkinson's disease is driven by normal aging alone.
To uncover the neural mechanisms behind early smell loss in neurodegenerative diseases, Dr. Adil Asghar and AIIMS researchers evaluated olfactory bulb volume (OBV) changes across various age groups. The study analyzed how this structural shrinkage directly correlates with clinical smell performance and the severe atrophy present in patients with Alzheimer’s and Parkinson’s disease.
Therefore, the systematic review of 29 high-resolution MRI studies evaluated olfactory bulb volume and smell function in healthy individuals alongside patients with Alzheimer's or Parkinson's disease. By strictly excluding low-quality data and animal studies, researchers accurately determined the exact rate of age-related volume shrinkage and its direct correlation with clinical smell tests.
Key Clinical Findings of the Review Includes:
• Baseline Volumetrics: Analysis revealed that the pooled mean OBV in healthy populations is 54.5 mm³ for the right and 55.56 mm³ for the left, presenting no statistically significant differences based on sex or anatomical laterality.
• Aging Impact: Analysis demonstrated a moderate negative correlation between age and OBV (r = -0.53 to -0.59, p < 0.05), effectively confirming progressive structural atrophy over a typical lifespan.
• Functional Correlation: Analysis showed that objective olfactory function test scores maintain a modest but significant correlation (r = 0.48, p < 0.01) with olfactory bulb size, directly linking structural volume to sensory performance.
• Disease Atrophy: Analysis identified substantially accelerated shrinkage in neurodegenerative cohorts, documenting severe volume reductions of 0.9 to 0.93 standard deviations (SD) in PD and 1 to 1.05 SD in AD when compared to healthy controls.
• Aging-Disease Interplay: Analysis calculated that approximately 43.3% of the severe olfactory bulb shrinkage observed in patients with PD is intrinsically driven by the natural aging process rather than the disease pathology alone.
The results suggest that age-related OBV reduction is a standard, normal physiological trajectory, but the highly pronounced structural shrinkage witnessed in clinical populations with AD (reaching up to 1.05 SD) and PD drastically exacerbates this baseline loss. Furthermore, recognizing that at least 40% of PD-associated olfactory bulb shrinkage is intrinsically age-related firmly reinforces its practical utility as an easily accessible biomarker for simultaneously monitoring both natural aging trajectories and pathological neurodegeneration.
Thus, the review concludes that integrating the structural volumetric evaluations of the olfactory bulb alongside routine clinical olfactory testing could gently enhance early diagnostic detection protocols for clinicians actively managing age-related and neurodegenerative health conditions.
While current cross-sectional research designs and variable imaging protocols restrict the capacity to firmly establish definitive causality, initiating broader, longitudinal investigations with heavily standardized methodologies would smoothly clarify the predictive timeline of olfactory bulb atrophy in disease progression.
Reference
Asghar, A., Narayan, R. K., Kumar, R., Sarangi, P. K., Patra, A., Kumar, A., & Zabihullah, M. (2025). Exploring Olfactory Bulb Volume and Its Shrinkage in Aging and Neurodegeneration: A Systematic Review and Meta-Analysis of Observational Studies. Indian Journal of Radiology and Imaging, 36(3), 374–393.
